US Stock MarketDetailed Quotes

SEEL Seelos Therapeutics

Watchlist

3.9000
-1.1000-22.00%

Close Sep 27 16:00 ET

3.9000
0.00000.00%

Post 20:01 ET

2.27MMarket Cap0.01P/E (TTM)

Seelos Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

83.54%-972K

55.14%-4.64M

61.18%-23.91M

85.40%-1.91M

48.09%-5.75M

71.05%-5.9M

39.29%-10.35M

-25.74%-61.6M

28.62%-13.09M

-5.37%-11.07M

Net income from continuing operations

105.80%1.71M

80.17%-2.66M

48.48%-37.88M

70.77%-5.45M

153.55%10.5M

-38.66%-29.5M

4.07%-13.43M

-11.33%-73.53M

31.56%-18.66M

-81.27%-19.6M

Operating gains losses

-125.35%-3.47M

-177.99%-3.61M

-2,928.77%-8.84M

-3,165.00%-3.27M

-26,370.33%-23.91M

28,063.27%13.7M

2,076.50%4.63M

-109.35%-292K

-174.63%-100K

219.74%91K

Depreciation and amortization

7.14%15K

7.55%57K

-71.70%15K

--14K

--53K

--0

Other non cash items

----

47.23%6.35M

-29.65%700K

-36.87%1.35M

----

-38.29%4.31M

-81.60%995K

11,772.22%2.14M

Change In working capital

-67.19%1.3M

117.87%456K

346.25%12.42M

38.15%5.13M

10.19%5.87M

508.54%3.97M

51.72%-2.55M

297.80%2.78M

256.69%3.71M

1,178.74%5.33M

-Change in receivables

115.47%780K

74.15%-205K

---763K

---542K

--210K

--362K

---793K

--0

-Change in prepaid assets

-93.48%206K

70.41%-414K

353.09%5.69M

-39.11%1.74M

73.57%2.19M

243.96%3.16M

66.43%-1.4M

22.36%-2.25M

530.12%2.86M

224.02%1.26M

-Change in payables and accrued expense

-28.29%332K

414.12%1.09M

20.75%7.55M

335.17%3.95M

-14.23%3.49M

-62.14%463K

-719.64%-347K

320.65%6.26M

153.20%907K

679.50%4.07M

-Change in other current liabilities

-7.14%-15K

-15.38%-15K

95.27%-58K

68.63%-16K

---15K

---14K

98.89%-13K

---1.23M

---51K

--0

Cash from discontinued investing activities

Operating cash flow

83.54%-972K

55.14%-4.64M

61.18%-23.91M

85.40%-1.91M

48.09%-5.75M

71.05%-5.9M

39.29%-10.35M

-25.74%-61.6M

28.62%-13.09M

-5.37%-11.07M

Investing cash flow

Cash flow from continuing investing activities

Cash from discontinued investing activities

Financing cash flow

Cash flow from continuing financing activities

132.09%742K

-75.55%2.17M

812.27%11.38M

223.04%2.32M

645.51%2.49M

-1,734.92%-2.31M

10,591.57%8.87M

-101.43%-1.6M

-109.33%-1.89M

133.57%334K

Net issuance payments of debt

92.00%-185K

-2.18%-1.31M

-304.71%-7.64M

-14.09%-2.15M

---1.89M

---2.31M

---1.29M

86.07%-1.89M

---1.89M

--0

Net common stock issuance

--927K

-65.54%3.48M

4,039.82%18.92M

--4.48M

850.33%4.34M

--0

--10.1M

-99.61%457K

--0

--457K

Proceeds from stock option exercised by employees

--0

-93.44%4K

-9.35%97K

--0

50.00%36K

--0

-26.51%61K

-98.57%107K

--0

-67.57%24K

Net other financing activities

----

---273K

--0

---147K

Cash from discontinued financing activities

Financing cash flow

132.09%742K

-75.55%2.17M

812.27%11.38M

223.04%2.32M

645.51%2.49M

-1,734.92%-2.31M

10,591.57%8.87M

-101.43%-1.6M

-109.33%-1.89M

133.57%334K

Net cash flow

Beginning cash position

-96.27%524K

-80.71%3M

-80.27%15.53M

-91.53%2.58M

-85.84%5.84M

-77.24%14.06M

-80.27%15.53M

402.71%78.73M

-60.29%30.51M

-52.69%41.25M

Current changes in cash

97.20%-230K

-67.71%-2.47M

80.16%-12.54M

102.75%412K

69.66%-3.26M

59.96%-8.22M

91.31%-1.47M

-200.20%-63.2M

-887.90%-14.98M

-3.60%-10.74M

End cash Position

-94.97%294K

-96.27%524K

-80.71%3M

-91.53%2.58M

-85.84%5.84M

-77.24%14.06M

-80.27%15.53M

-60.29%30.51M

Free cash flow

83.54%-972K

55.14%-4.64M

61.18%-23.91M

85.40%-1.91M

48.09%-5.75M

71.05%-5.9M

39.29%-10.35M

-25.74%-61.6M

28.62%-13.09M

-5.37%-11.07M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	83.54%-972K	55.14%-4.64M	61.18%-23.91M	85.40%-1.91M	48.09%-5.75M	71.05%-5.9M	39.29%-10.35M	-25.74%-61.6M	28.62%-13.09M	-5.37%-11.07M
Net income from continuing operations	105.80%1.71M	80.17%-2.66M	48.48%-37.88M	70.77%-5.45M	153.55%10.5M	-38.66%-29.5M	4.07%-13.43M	-11.33%-73.53M	31.56%-18.66M	-81.27%-19.6M
Operating gains losses	-125.35%-3.47M	-177.99%-3.61M	-2,928.77%-8.84M	-3,165.00%-3.27M	-26,370.33%-23.91M	28,063.27%13.7M	2,076.50%4.63M	-109.35%-292K	-174.63%-100K	219.74%91K
Depreciation and amortization	7.14%15K	7.14%15K	7.55%57K	-71.70%15K	--14K	--14K	--14K	--53K	--53K	--0
Other non cash items	----	----	47.23%6.35M	-29.65%700K	-36.87%1.35M	----	----	-38.29%4.31M	-81.60%995K	11,772.22%2.14M
Change In working capital	-67.19%1.3M	117.87%456K	346.25%12.42M	38.15%5.13M	10.19%5.87M	508.54%3.97M	51.72%-2.55M	297.80%2.78M	256.69%3.71M	1,178.74%5.33M
-Change in receivables	115.47%780K	74.15%-205K	---763K	---542K	--210K	--362K	---793K	--0	--0	--0
-Change in prepaid assets	-93.48%206K	70.41%-414K	353.09%5.69M	-39.11%1.74M	73.57%2.19M	243.96%3.16M	66.43%-1.4M	22.36%-2.25M	530.12%2.86M	224.02%1.26M
-Change in payables and accrued expense	-28.29%332K	414.12%1.09M	20.75%7.55M	335.17%3.95M	-14.23%3.49M	-62.14%463K	-719.64%-347K	320.65%6.26M	153.20%907K	679.50%4.07M
-Change in other current liabilities	-7.14%-15K	-15.38%-15K	95.27%-58K	68.63%-16K	---15K	---14K	98.89%-13K	---1.23M	---51K	--0
Cash from discontinued investing activities
Operating cash flow	83.54%-972K	55.14%-4.64M	61.18%-23.91M	85.40%-1.91M	48.09%-5.75M	71.05%-5.9M	39.29%-10.35M	-25.74%-61.6M	28.62%-13.09M	-5.37%-11.07M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities	132.09%742K	-75.55%2.17M	812.27%11.38M	223.04%2.32M	645.51%2.49M	-1,734.92%-2.31M	10,591.57%8.87M	-101.43%-1.6M	-109.33%-1.89M	133.57%334K
Net issuance payments of debt	92.00%-185K	-2.18%-1.31M	-304.71%-7.64M	-14.09%-2.15M	---1.89M	---2.31M	---1.29M	86.07%-1.89M	---1.89M	--0
Net common stock issuance	--927K	-65.54%3.48M	4,039.82%18.92M	--4.48M	850.33%4.34M	--0	--10.1M	-99.61%457K	--0	--457K
Proceeds from stock option exercised by employees	--0	-93.44%4K	-9.35%97K	--0	50.00%36K	--0	-26.51%61K	-98.57%107K	--0	-67.57%24K
Net other financing activities	----	----	----	----	----	----	----	---273K	--0	---147K
Cash from discontinued financing activities
Financing cash flow	132.09%742K	-75.55%2.17M	812.27%11.38M	223.04%2.32M	645.51%2.49M	-1,734.92%-2.31M	10,591.57%8.87M	-101.43%-1.6M	-109.33%-1.89M	133.57%334K
Net cash flow
Beginning cash position	-96.27%524K	-80.71%3M	-80.27%15.53M	-91.53%2.58M	-85.84%5.84M	-77.24%14.06M	-80.27%15.53M	402.71%78.73M	-60.29%30.51M	-52.69%41.25M
Current changes in cash	97.20%-230K	-67.71%-2.47M	80.16%-12.54M	102.75%412K	69.66%-3.26M	59.96%-8.22M	91.31%-1.47M	-200.20%-63.2M	-887.90%-14.98M	-3.60%-10.74M
End cash Position	-94.97%294K	-96.27%524K	-80.71%3M	-80.71%3M	-91.53%2.58M	-85.84%5.84M	-77.24%14.06M	-80.27%15.53M	-80.27%15.53M	-60.29%30.51M
Free cash flow	83.54%-972K	55.14%-4.64M	61.18%-23.91M	85.40%-1.91M	48.09%-5.75M	71.05%-5.9M	39.29%-10.35M	-25.74%-61.6M	28.62%-13.09M	-5.37%-11.07M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data